{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:58:42Z","timestamp":1780066722441,"version":"3.54.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["2T37MD001368"],"award-info":[{"award-number":["2T37MD001368"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R15 AI047115"],"award-info":[{"award-number":["2R15 AI047115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI100560"],"award-info":[{"award-number":["R01AI100560"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["SC3GM125556"],"award-info":[{"award-number":["SC3GM125556"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cleveland Department of Veterans Affairs","award":["1I01BX001974"],"award-info":[{"award-number":["1I01BX001974"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cefiderocol (CFDC) is a novel chlorocatechol-substituted siderophore antibiotic approved to treat complicated urinary tract infections (cUTI) and hospital-acquired and ventilator-acquired pneumonia (HAP\/VAP). Previous work determined that albumin-rich human fluids increase the minimum inhibitory concentration (MICs) of <jats:italic>Acinetobacter baumannii<\/jats:italic> against CFDC and reduce the expression of genes related to iron uptake systems. This latter effect may contribute to the need for higher concentrations of CFDC to inhibit growth. The presence of human urine (HU), which contains low albumin concentrations, did not modify MIC values of two carbapenem-resistant\u00a0<jats:italic>A. baumannii<\/jats:italic>. Levels of resistance to CFDC were not modified by HU in strain AMA40 but were reduced in strain AB5075. Expanding the studies to other carbapenem-resistant\u00a0<jats:italic>A. baumannii<\/jats:italic>\u00a0isolates showed that the presence of HU resulted in unmodified or reduced MIC of CDFC values. The expression of\u00a0<jats:italic>piuA<\/jats:italic><jats:italic>, <\/jats:italic><jats:italic>pirA<\/jats:italic><jats:italic>, <\/jats:italic><jats:italic>bauA<\/jats:italic>, and\u00a0<jats:italic>bfnH<\/jats:italic>\u00a0determined by qRT-PCR was enhanced in <jats:italic>A. baumannii<\/jats:italic> AMA40 and AB5075 by the presence of HU in the culture medium. All four tested genes code for functions related to recognition and transport of ferric-siderophore complexes. The effect of HU on expression of <jats:italic>pbp1<\/jats:italic>,\u00a0<jats:italic>pbp3,\u00a0bla<\/jats:italic><jats:sub>OXA-51-like<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>ADC<\/jats:sub>, and\u00a0<jats:italic>bla<\/jats:italic><jats:sub>NDM-1<\/jats:sub>, genes associated with resistance to \u03b2-lactams, as well as genes coding for efflux pumps and porins was variable, showing dependence with the strain analyzed. We conclude that the lack of significant concentrations of albumin and free iron in HU makes this fluid behave differently from others we tested. Unlike other albumin rich fluids, the presence of HU does not impact the antibacterial activity of CFDC when tested against <jats:italic>A. baumannii.<\/jats:italic><\/jats:p>","DOI":"10.1038\/s41598-022-12829-7","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T16:22:56Z","timestamp":1653409376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Acinetobacter baumannii response to cefiderocol challenge in human urine"],"prefix":"10.1038","volume":"12","author":[{"given":"Brent","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Escalante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisel R.","family":"Tuttobene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Subils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyanka","family":"Mezcord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nardin","family":"Georgeos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Pasteran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Sieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Actis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo E.","family":"Tolmasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Soledad","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"12829_CR1","doi-asserted-by":"publisher","first-page":"e46984","DOI":"10.1371\/journal.pone.0046984","volume":"7","author":"AY Peleg","year":"2012","unstructured":"Peleg, A. Y. et al. The success of acinetobacter species; genetic, metabolic and virulence attributes. PLoS ONE 7, e46984 (2012).","journal-title":"PLoS ONE"},{"key":"12829_CR2","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","volume":"21","author":"AY Peleg","year":"2008","unstructured":"Peleg, A. Y., Seifert, H. & Paterson, D. L. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538\u2013582 (2008).","journal-title":"Clin. Microbiol. Rev."},{"key":"12829_CR3","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/CCM.0000000000000181","volume":"42","author":"B Spellberg","year":"2014","unstructured":"Spellberg, B. & Bonomo, R. A. The deadly impact of extreme drug resistance in Acinetobacter baumannii. Crit. Care Med. 42, 1289\u20131291 (2014).","journal-title":"Crit. Care Med."},{"key":"12829_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","volume":"16","author":"CM Harding","year":"2018","unstructured":"Harding, C. M., Hennon, S. W. & Feldman, M. F. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat. Rev. Microbiol. 16, 91\u2013102 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"12829_CR5","unstructured":"CDC. Antibiotic Resistance Threats in the United States (US Department of Health and Human Services, CDC, 2019)."},{"key":"12829_CR6","unstructured":"WHO. Antimicrobial Resistance Global Report on surveillance 2014. (World Health Organization, WHO)."},{"key":"12829_CR7","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1038\/s41467-019-10706-y","volume":"10","author":"G Di Venanzio","year":"2019","unstructured":"Di Venanzio, G. et al. Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumannii chromosomal genes. Nat. Commun. 10, 2763 (2019).","journal-title":"Nat. Commun."},{"key":"12829_CR8","first-page":"312","volume":"16","author":"R Ding","year":"2019","unstructured":"Ding, R., Li, X., Zhang, X., Zhang, Z. & Ma, X. The epidemiology of symptomatic catheter-associated urinary tract infections in the intensive care unit: A 4-year single center retrospective study. Urol. J. 16, 312\u2013317 (2019).","journal-title":"Urol. J."},{"key":"12829_CR9","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1093\/infdis\/jiw529","volume":"215","author":"GL Murray","year":"2017","unstructured":"Murray, G. L. et al. Global gene expression profile of Acinetobacter baumannii during bacteremia. J Infect Dis 215, S52\u2013S57 (2017).","journal-title":"J Infect Dis"},{"key":"12829_CR10","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.1038\/s41598-018-33072-z","volume":"8","author":"B Quinn","year":"2018","unstructured":"Quinn, B. et al. Human serum albumin alters specific genes that can play a role in survival and persistence in Acinetobacter baumannii. Sci. Rep. 8, 14741 (2018).","journal-title":"Sci. Rep."},{"key":"12829_CR11","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1038\/s41598-021-81714-6","volume":"11","author":"J Martinez","year":"2021","unstructured":"Martinez, J. et al. Cerebrospinal fluid (CSF) augments metabolism and virulence expression factors in Acinetobacter baumannii. Sci. Rep. 11, 4737 (2021).","journal-title":"Sci. Rep."},{"key":"12829_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/pathogens10040471","volume":"10","author":"C Pimentel","year":"2021","unstructured":"Pimentel, C. et al. Human pleural fluid and human serum albumin modulate the behavior of a hypervirulent and multidrug-resistant (MDR) Acinetobacter baumannii representative strain. Pathogens 10, 471 (2021).","journal-title":"Pathogens"},{"key":"12829_CR13","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3389\/fmicb.2019.01581","volume":"10","author":"MJ Rodman Nyah","year":"2019","unstructured":"Rodman Nyah, M. J. et al. Human pleural fluid elicits pyruvate and phenylalanine metabolism in Acinetobacter baumannii to enhance cytotoxicity and immune evasion. Front. Microbiol. 10, 1581 (2019).","journal-title":"Front. Microbiol."},{"key":"12829_CR14","doi-asserted-by":"publisher","first-page":"17251","DOI":"10.1038\/s41598-019-53847-2","volume":"9","author":"J Martinez","year":"2019","unstructured":"Martinez, J. et al. Human pleural fluid triggers global changes in the transcriptional landscape of Acinetobacter baumannii as an adaptive response to stress. Sci. Rep. 9, 17251 (2019).","journal-title":"Sci. Rep."},{"key":"12829_CR15","doi-asserted-by":"publisher","first-page":"e01019-21","DOI":"10.1128\/AAC.01019-21","volume":"65","author":"C Le","year":"2021","unstructured":"Le, C. et al. Interplay between meropenem and human serum albumin on expression of carbapenem resistance genes and natural competence in Acinetobacter baumannii. Antimicrob. Agents Chemother. 65, e01019-21 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"12829_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/antibiotics10070833","volume":"10","author":"C Pimentel","year":"2021","unstructured":"Pimentel, C. et al. Interaction of Acinetobacter baumannii with human serum albumin: Does the host determine the outcome?. Antibiotics 10, 833 (2021).","journal-title":"Antibiotics"},{"key":"12829_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/biomedicines10030600","volume":"10","author":"C Le","year":"2022","unstructured":"Le, C. et al. Human serum proteins and susceptibility of Acinetobacter baumannii to cefiderocol: Role of iron transport. Biomedicines 10, 600 (2022).","journal-title":"Biomedicines"},{"key":"12829_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1473-3099(18)30721-7","volume":"19","author":"S Portsmouth","year":"2019","unstructured":"Portsmouth, S., Echols, R. & Den Nagata, T. Cefiderocol for treatment of complicated urinary tract infections. Lancet Infect. Dis. 19, 23\u201324 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"12829_CR19","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S1473-3099(18)30554-1","volume":"18","author":"S Portsmouth","year":"2018","unstructured":"Portsmouth, S. et al. Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: A phase 2, randomised, double-blind, non-inferiority trial. Lancet Infect. Dis. 18, 1319\u20131328 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"12829_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/apm.12992","volume":"127","author":"Z Aghajani","year":"2019","unstructured":"Aghajani, Z., Rasooli, I. & Mousavi Gargari, S. L. Exploitation of two siderophore receptors, BauA and BfnH, for protection against Acinetobacter baumannii infection. APMIS 127, 753\u2013763 (2019).","journal-title":"APMIS"},{"key":"12829_CR21","doi-asserted-by":"publisher","first-page":"e1008995","DOI":"10.1371\/journal.ppat.1008995","volume":"16","author":"JR Sheldon","year":"2020","unstructured":"Sheldon, J. R. & Skaar, E. P. Acinetobacter baumannii can use multiple siderophores for iron acquisition, but only acinetobactin is required for virulence. PLoS Pathog. 16, e1008995 (2020).","journal-title":"PLoS Pathog."},{"key":"12829_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1574-695X.2011.00926.x","volume":"64","author":"AC Jacobs","year":"2012","unstructured":"Jacobs, A. C. et al. Characterization of the Acinetobacter baumannii growth phase-dependent and serum responsive transcriptomes. FEMS Immunol. Med. Microbiol. 64, 403\u2013412 (2012).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"12829_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/ijms18020458","volume":"18","author":"Z Ni","year":"2017","unstructured":"Ni, Z., Chen, Y., Ong, E. & He, Y. Antibiotic resistance determinant-focused Acinetobacter baumannii vaccine designed using reverse vaccinology. Int. J. Mol. Sci. 18, 458 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"12829_CR24","doi-asserted-by":"publisher","first-page":"e02531-16","DOI":"10.1128\/AAC.02531-16","volume":"61","author":"L Moynie","year":"2017","unstructured":"Moynie, L. et al. Structure and function of the PiuA and PirA siderophore-drug receptors from Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrob. Agents Chemother. 61, e02531-16 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"12829_CR25","doi-asserted-by":"publisher","first-page":"e01076-14","DOI":"10.1128\/mBio.01076-14","volume":"5","author":"AC Jacobs","year":"2014","unstructured":"Jacobs, A. C. et al. AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. MBio 5, e01076-14 (2014).","journal-title":"MBio"},{"key":"12829_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jgar.2020.08.015","volume":"23","author":"D Rodgers","year":"2020","unstructured":"Rodgers, D. et al. Characterisation of ST25 NDM-1-producing Acinetobacter spp. strains leading the increase in NDM-1 emergence in Argentina. J. Glob. Antimicrob. Resist. 23, 108\u2013110 (2020).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"12829_CR27","doi-asserted-by":"publisher","first-page":"e00324-20","DOI":"10.1128\/AAC.00324-20","volume":"64","author":"MD Adams","year":"2020","unstructured":"Adams, M. D. et al. Distinct mechanisms of dissemination of NDM-1 metallo-beta-lactamase in Acinetobacter spp. in Argentina. Antimicrob. Agents Chemother. 64, e00324-20 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"12829_CR28","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1128\/AAC.00778-06","volume":"50","author":"KM Hujer","year":"2006","unstructured":"Hujer, K. M. et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother. 50, 4114\u20134123 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"12829_CR29","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"12829_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows\u2013Wheeler transform. Bioinformatics 26, 589\u2013595 (2010).","journal-title":"Bioinformatics"},{"key":"12829_CR31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): High-performance genomics data visualization and exploration. Brief Bioinform. 14, 178\u2013192 (2013).","journal-title":"Brief Bioinform."},{"key":"12829_CR32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"12829_CR33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"12829_CR34","unstructured":"(CLSI) CLSI. Performance standards for antimicrobial susceptibility testing: Thirty Edition informational supplement. CLSI Document M100-S30:2020 (Clinical Lab Standards Institute, 2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12829-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12829-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12829-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:31:20Z","timestamp":1669347080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12829-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12829"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12829-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8763"}}